New Delhi: Foreign Minister S Jaishankar said he had increased the problem of European authorization for the Covishield vaccine to travel to the EU with high representatives for the EU in foreign policy, Josep Borell Fontelles.
Tweeting After his meeting with Borell on the sidelines of the G-20 Foreign Minister meeting in Matera, Jaishankar said, “discuss the production of vaccines and access.
Take the authorization of ‘covishield’ to travel to Europe.
Will follow up.” The ‘Vaccine Vaccine Vaccine program is’ Uni Europe, officially called ‘Green Pass’, has agreed to only four vaccines, Vaxzevria (Oxford-Astrazeneca), Comirnaty (Pfizer-Bionth), SpikeVax (Moderna) and Janssen-Johnson & Johnson.
In an effort to clean the air with a Covid Pass Green certificate, the European Union said that individual countries have the power to approve the vaccine that cleanses foreigners to their countries.
“For the purpose of Covid digital certificates, individual member countries will have the option to accept vaccinations that have been authorized by the World Health Organization (WHO), such as Covishield.” Earlier on Tuesday, the Serum Institute source said they had submitted approval to the European Medical Agency (EMA) for the Covishield vaccine through Astrazeneca.
Because this is exactly the same as the Vaxzevria Jab produced in the EU, there has been a counter-attack on EMA’s decision to clean the last but not the first.
However, EMA said on Tuesday they had not received the application for the Covishield vaccine approval by SII.
“Regarding the possibility of an EMA authorization for the Covishield, yesterday, the European Medical Agency (EMA) stated that it had not received an agreement request.
This will check the request when it is received, according to its procedure.
EMA does not investigate new drugs itself, unless requested by the company Related to.
“Some officials say all companies that produce astrazeneca vaccines must apply separately for approval.
The European Union has the right relationship with Astra-Zeneca from the beginning of the vaccine process.